The global anti-asthmatic drugs market is anticipated to grow at a significant CAGR of 8.2% during the forecast period. Asthma is a condition that causes the respiratory tract to become thin and swollen and produce more mucus. It can make breathing difficult, causing coughing, shortness of breath, and shortness of breath in asthma patients. According to the WHO, asthma is most common non-communicable disease in children and 15.0-18.0% cases are found in developed countries, every year. Asthma is most of the common chronic diseases in children. Furthermore, as per the study conducted by National Health and Planning Commission in 2019, 30 million people in China suffered from asthma and only 28% of the people with asthma have their condition under control. The growth is fueled by the increasing prevalence of asthma, rising the demand for long-term control medication and rescue medication across the globe. For instance, in September 2019, Novartis announced the positive results from the phase III IRIDIUM study of inhaled combination QVM149 in patients diagnosed with uncontrolled asthma.

Impact of COVID-19 on Global Anti-Asthmatic Drugs Market

The global is global anti-asthmatic drugs was hit by the outbreak of COVID-19 in December 2019.  The drug and device shortage during the COVID pandemic has gained pharma companies' interest in delivering quickly. The outbreak of COVID-19 has disrupted the supply of raw materials and products across the globe, hence impacted the congenital heart disease market negatively. For instance, according to the National Institute of Health of the US, medication shortages in 2020 have been shown at 87 % as compared to 2019. Further, COVID-19 affected people who have moderate-to-severe asthma or uncontrolled asthma. According to World Health Organization (WHO), most people with asthma, particularly those with non-allergic asthma, are at a slightly higher risk of serious disease from COVID-19 than the general population. 

Segmental Outlook 

The global anti-asthmatic drugs market is segmented based on the type, and application. Based on the type, the market is segmented into long-term control medications, quick-relief medications, and medications for allergy-induced asthma. Based on the application, the market is sub-segmented into the hospital pharmacy, retail pharmacy, and online pharmacy. The above-mentioned segments can be customized as per the requirements. Among these, the online pharmacy segment is anticipated to propel the growth of the market over the forecast period. Further, driving the online penetration compared to offline or retail stores.

Global Anti-Asthmatic Drugs Market Share by Application, 2021 (%)

The Online Pharmacy Segment is Anticipated to Hold a Prominent Share in the Global Anti-Asthmatic Drugs Market

Online pharmacy is anticipated to hold the largest share in the market. The attributable factor for growth of the segment is rising internet penetration. For instance, according to China government-backed Market Intelligence & Consulting Institute and reported by China Internet Watch, internet penetration in China reached 61.2% in the first half of 2019, with 854 million internet users at the end of June 2019. Further, due to the COVID-19 pandemic, there were temporary shutdowns and restrictions on going out to curb the spread of the virus owing to which people started preferring online shopping. 

Regional Outlooks

The global anti-asthmatic drugs market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America).  The market can be analyzed for a particular region or country level as per the requirement. The Asia-Pacific regional anti-asthmatic drugs market is expected to hold a prominent market share due to the presence of several key market players.

Global Anti-Asthmatic Drugs Market Growth, by Region 2022-2028

The Asia-Pacific Region is estimated to Hold the Major Share in the Global Anti-Asthmatic Drugs Market

The Asia-Pacific is anticipated to hold a prominent share in the market. The anti-asthmatic drugs market is attributed to rapid urbanization and growing healthcare expenditure due to increased awareness among the patients about the chronic nature of asthma & its treatment options. Additionally, the increasing incidence rates and greater patient pool are expected to have a positive impact on the growth trends during the forecast period. As per the Institute of Health Metrics and Evaluation (IHME), the values for the prevalence of asthma in China in the year 2015 was 19.5 million peoples, which increased up to 24.8 million in 2019. The high prevalence of asthma in China has driven the demand for its treatment that includes drugs and bronchial thermoplasty.

Market Players Outlook

The major companies serving the global anti-asthmatic drugs market include Novartis International AG, Sanofi SA, Regeneron Pharmaceuticals Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2021, Amgen announced the approval of Amgen and AstraZeneca's Tezspire from the US Food and Drug Administration. It is used as an add-on maintenance treatment of severe asthma in adult and pediatric patients of age 12 years and adults.

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global anti-asthmatic drugs market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.